<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Colomb Med (Cali)</journal-id><journal-id journal-id-type="iso-abbrev">Colomb. Med</journal-id><journal-title-group><journal-title>Colombia M&#x000e9;dica : CM</journal-title></journal-title-group><issn pub-type="ppub">0120-8322</issn><issn pub-type="epub">1657-9534</issn><publisher><publisher-name>Universidad del Valle</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25100892</article-id><article-id pub-id-type="pmc">4123585</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Caffeine modifies blood glucose availability during prolonged low-intensity exercise in individuals with type-2 diabetes </article-title><trans-title-group xml:lang="es"><trans-title>Cafe&#x000ed;na altera la disponibilidad de glucosa en sangre durante ejercicio prolongado de baja intensidad en diab&#x000e9;ticos tipo 2
</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name><surname>da Silva</surname><given-names>Luiz Augusto</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>de Freitas</surname><given-names>Leandro</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Medeiros</surname><given-names>Thiago Emannuel</given-names></name><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Osiecki</surname><given-names>Raul</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Garcia Michel</surname><given-names>Renan</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Snak</surname><given-names>Andr&#x000e9; Luiz</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Maneck Malfatti</surname><given-names>Carlos Ricardo</given-names></name><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Midwest State University of Parana, Pharmaceutical Science Postgraduate Program, 
Guarapuava, PR, <country>Brazil</country></aff><aff id="aff2"><label>2</label>State University of Santa Catarina, Physical Education Postgraduate Program, Florian&#x000f3;polis, SC, <country>Brazil</country></aff><aff id="aff3"><label>3</label>Federal University of Parana, Department of Physical Education, Curitiba, PR, <country>Brazil</country></aff><aff id="aff4"><label>4</label>Campo Real College, Department of Biomedicine, Guarapuava, PR, <country>Brazil</country></aff><aff id="aff5"><label>5</label>Midwest State University of Parana, Department of Physiotherapy, Guarapuava, PR, <country>Brazil</country></aff><author-notes><corresp id="c05"> Carlos Ricardo Maneck Malfatti, PhD. Department of Physiotherapy
Rua Sime&#x000e3;o Camargo Varela de S&#x000e1;, 03, 84015-430; Guarapuava- PR, Brazil
Phone: (55 42) 3621 1000; FAX: (55 42) 3621-1090
e-mail: <email>crmalfatti@gmail.com</email></corresp><fn id="fn01" fn-type="conflict"><p>
<bold>Conflict of Interest: </bold>All authors do not have any possible conflicts of interest</p></fn></author-notes><pub-date date-type="pub" publication-format="electronic" iso-8601-date="2014-06-30"><day>30</day><month>6</month><year>2014</year></pub-date><pub-date date-type="collection" publication-format="electronic"><season>Apr-Jun</season><year>2014</year></pub-date><volume>45</volume><issue>2</issue><fpage>72</fpage><lpage>76</lpage><history><date date-type="received"><day>09</day><month>12</month><year>2013</year></date><date date-type="rev-recd"><day>22</day><month>4</month><year>2014</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2014</year></date></history><permissions><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p>&#x000a9; 2014 Universidad del Valle. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract><sec><title>Objective:</title><p> The study investigated the effect of supplementation with maltodextrin (CHO) alone or associated to caffeine during exercise in T2DM subjects. 
</p></sec><sec><title>Methods:</title><p> Pilot study, using eight subjects with T2DM, aged 55&#x000b1;10 years, received CHO (1 g/kg) or caffeine (1.5 mg/kg) alone or associated before exercise protocol. The exercise was executed at 40% heart rate (HR) reserve for 40 min, with 10-min recovery. Blood pressure (BP) and perceived exertion scale (Borg) were checked every 2 min. Blood glucose (BG) was checked every 10 min. For statistical analysis, ANOVA test was used and the value was considered statistically significant at <italic>p</italic> &#x0003c;0.05. 
</p></sec><sec><title>Results:</title><p> The results showed that BP and HR did not change significantly among all treatments. Caffeine promoted a significant reduction in BG of 75 mg/dL (65%, <italic>p</italic> &#x0003c;0.05) during 40 min of exercise protocol compared to all groups. 
</p></sec><sec><title>Conclusion:</title><p> Supplementation with 1.5 mg/kg of caffeine reduces BG concentration during prolonged exercise in T2DM patients.
</p></sec></abstract><trans-abstract xml:lang="es"><sec><title>Objectivo:</title><p> Investigar los efectos de la suplementaci&#x000f3;n con maltodextrina (CHO) s&#x000f3;lo o combinado con cafe&#x000ed;na durante el ejercicio en sujetos con diabetes tipo 2 . 
</p></sec><sec><title>M&#x000e9;todos:</title><p> Estudio piloto que incluy&#x000f3; ocho sujetos con DM2, de 55&#x000b1;10 a&#x000f1;os, el CHO (1g/kg) o cafe&#x000ed;na (1.5 mg/kg) s&#x000f3;lo o combinado antes del protocolo de ejercicio. El ejercicio se realiz&#x000f3; a 40% de la frecuencia cardiaca (FC). Reserva del coraz&#x000f3;n durante 40 min con 10 min de recuperaci&#x000f3;n. La presi&#x000f3;n arterial (PA) y la escala de esfuerzo (Borg) fueron revisadas cada 2 min. La glucosa en sangre (GS) se comprob&#x000f3; cada 10 min. El an&#x000e1;lisis estad&#x000ed;stico se realiz&#x000f3; mediante ANOVA, y consider&#x000f3; significaci&#x000f3;n estad&#x000ed;stica un valor de <italic>p</italic> &#x0003c;0.05. 
</p></sec><sec><title>Resultados:</title><p> Los resultados muestran que PA, FC y Borg no difiri&#x000f3; significativamente entre los tratamientos. La cafe&#x000ed;na promueve una reducci&#x000f3;n significativa en los niveles de glucosa en la sangre de 75 mg/dL (65%, <italic>p</italic> &#x0003c;0.05), durante un protocolo de ejercicio de 40 min en comparaci&#x000f3;n con todos los grupos. 
</p></sec><sec><title>Conclusiones:</title><p> Suplementaci&#x000f3;n con 1.5 mg/kg de cafe&#x000ed;na redujo significativamente los niveles de GS durante el protocolo de ejercicio en pacientes con DM2 .
</p></sec></trans-abstract><kwd-group><kwd>Diabetes <italic>mellitus</italic></kwd><kwd>caffeine</kwd><kwd>supplementary feeding</kwd><kwd>exercise</kwd></kwd-group><counts><fig-count count="1"/><table-count count="2"/><ref-count count="31"/><page-count count="5"/></counts></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Diet and glycemic control during exercise is very important, preventing or delaying complications during and after exercise, like hyperglycemia or hypoglycemia, frequently detected in non-monitored diabetic patients. In addition, blood glucose (BG) control has a positive impact on long-term clinical outcomes in individuals with diabetes by delaying the onset and slowing the progression of serious diabetes-associated complications <xref rid="B01" ref-type="bibr">1</xref>.</p><p>The postprandial BG response is related to overall glucose control <xref rid="B02" ref-type="bibr">2</xref> and it is significantly affected by the amount and type of carbohydrate (CHO) and the rate of carbohydrate digestion <xref rid="B03" ref-type="bibr">3</xref>. Slower rates of CHO digestion and absorption after a low-glycemic index meal result in a smaller rise in postprandial BG and a smaller rise in insulin <xref rid="B04" ref-type="bibr">4</xref>. Furthermore, diet modifications designed for people with diabetes may provide other benefits besides BG control in rest and during exercise <xref rid="B05" ref-type="bibr">5</xref>. The observed improvements in exercise performance with CHO ingestion have been attributed to maintenance of plasma glucose and glycogen availability <xref rid="B06" ref-type="bibr">6</xref>. Elevation of BG associated with supplementation is suggested to improve aerobic performance through reduction of muscle glycogen use or through the use of BG as a predominant fuel source as glycogen becomes depleted <xref rid="B07" ref-type="bibr">7</xref>. A recent study characterized the better dose for CHO supplementation, improved glycogen availability in muscle and liver. The CHO supplementation before exercise increased muscle and hepatic glycogen storage after prolonged exercise only by 1.0 g/kg in liver and 2.0 g/kg in muscle without insulin and lipid oxidation alterations <xref rid="B08" ref-type="bibr">8</xref>.</p><p>In diabetic patients, diet control and BG availability pre-exercise is very important, avoiding risk situations during exercise. Prior studies revealed that diet manipulation pre-exercise, like caffeine supplementation can be employed as an ergogenic agent for a wide range of exercise conditions <xref rid="B09" ref-type="bibr">9</xref> and it is often proposed that this effect is mediated by enhancing fat oxidation and decreasing CHO use in active muscles, but without mechanisms to support this theory. In fact, caffeine can directly antagonize adenosine receptors in many tissues, including tissues in the central nervous and cardiovascular systems and skeletal muscle and adipose tissue. This could result in a multitude of responses including adrenaline and noradrenalin secretion, altered blood flow, increased sympathetic nerve activity and blood pressure (BP) and increased BG and triglyceride mobilization <xref rid="B10" ref-type="bibr">10</xref>. </p><p>Awareness of the impact of caffeine on glucose availability in type 2 diabetes mellitus (T2DM) patients is rare and very limited. Thus this study was performed to verify BG availability and cardiovascular alterations during aerobic exercise in diabetic patients pre-exercise CHO associated with caffeine feeding. </p></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title>Subjects</title><p>The pilot study group consisted of eight T2DM patients; aged 55&#x000b1;10 years (see clinical conditions on <xref ref-type="table" rid="t01">Table 1</xref>). The subjects received maltodextrin (1 g/kg), caffeine (1.5 mg/kg), caffeine associated with maltodextrin (caffeine and maltodextrin drink) or placebo prior to testing. Informed consent was obtained for the study in accordance to Resolution of the National Council of Health, which was approved by the Ethics Committee of the Midwest State University of Parana (p.79538/2012).</p><p>
<table-wrap id="t01" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Clinical characteristics of subjects (n= 8) </title></caption><graphic xlink:href="1657-9534-cm-45-02-00072-gt01"/></table-wrap>
</p></sec><sec><title>Inclusion and exclusion criteria </title><p> The study only included patients with medical diagnosis of T2DM in accordance with the Report by the Expert Committee on the Diagnosis and Classification of Diabetes mellitus <xref rid="B11" ref-type="bibr">11</xref>, these subjects were free of other complications (cardiovascular disease, nephropathy, neuropathy, or retinopathy), as confirmed by their physicians. All subjects, but one, were considered non-caffeine users as defined by the consumption of &#x0003c;2 caffeinated coffee or tea beverages and/or &#x0003c;5 caffeine-containing soft drinks per week. Twelve hours prior to oral supplementation and exercise execution, hypertensive and diabetic medications were suppressed.</p></sec><sec><title>Protocol of physical exercise</title><p>Indirect VO<sub>2max</sub> was determined by using the Mile test protocol by Kline <italic>et al</italic>
<xref rid="B12" ref-type="bibr">12</xref>. The exercise protocol was performed by using a treadmill ergometer. Patients were asked to exercise at 40% heart rate (HR), reserve for 40 min, followed by a 10-min passive recovery rate (HRmax) for age (using tables from the American Heart Association). The exercise rate was adjusted for individuals to find intensity in 40% of HR reserve.</p></sec><sec><title>Oral supplementation</title><p>The subjects received maltodextrin [1g/kg; Design Nutrition Advanced (DNA)] or caffeine (1.5 mg/kg; SIGMA reagents) or Maltodextrin associated with caffeine in the same prior doses or placebo (3.5 g of CHO; light tangerine juice) dissolved in distilled water 30 min before exercise. Patients were fasted 8 h before supplementations. In addition, they were instructed to follow a diet with no caffeine-containing products and alcohol, and avoid strenuous physical activity two days before the experiments.</p></sec><sec><title>Laboratory analysis </title><p>Prior to the prescription of exercise and treatments (one week before), the patients were evaluated in the laboratory, to obtain the biochemical, physiological, anthropometric and physical information. Body mass and height were measured by using anthropometrical devices (Welmy Corp., USA). Body fat was measured by means of the skinfolds technique <xref rid="B13" ref-type="bibr">13</xref>
<sup>,</sup>
<xref rid="B14" ref-type="bibr">14</xref> using a skinfold caliper (Cescorf Corp., USA). </p><p>Cardiovascular parameters of BP (mercury column) and HR (Polar-T-61) were measured at rest, during different moments and after exercise session (checked every 2 min). The subjective perceived exertion and pain was rated by the Borg and Pain scale, respectively, used during exercise sessions <xref rid="B15" ref-type="bibr">15</xref>
<sup>,</sup>
<xref rid="B16" ref-type="bibr">16</xref>.</p><p>Venous blood samples (5 mL) were drawn randomly for biochemistry laboratory at 9.00 a.m., and were centrifuged at 1,500 rpm during 8 min for plasma separation. Plasma triglycerides, cholesterol and glucose were dosed by glycerol phosphate oxidase/peroxidase and oxidase/peroxidase assay, respectively. In all methods, a BioSystems register kit was used.</p><p>Capillary blood samples (25 &#x000b5;L) were used to determine glucose concentrations during exercise during different moments (checked every 10 min) using a digital glucosimeter (ACCU - CHEK Performa<italic>, </italic>Roche<sup>&#x000ae;)</sup>.</p></sec><sec><title>Statistical analyses</title><p>All data are expressed as means &#x000b1; SEM. Statistical analysis was carried out by one-way analysis of variance (ANOVA) and <italic>F</italic>-values are presented only if <italic>p</italic> &#x0003c;0.05.<italic> Post hoc</italic> analysis was carried out, whenever appropriate, by the Tukey test.</p></sec></sec><sec sec-type="results"><title>Results</title><p> Within the exercise protocol, the patients were subjected to HR of predominant intensity at 40% of HR reserve. This intensity is in accordance with recent ADA recommendations <xref rid="B17" ref-type="bibr">17</xref> for diabetic patients. <xref ref-type="table" rid="t02">Table 2</xref> shows a similar cardiac work in different phases during 40 min of aerobic exercise, followed for 10 min of recovery period, which did not show any significant difference among treatments. Hence, systolic and diastolic BP were not different during the same protocol. The present results can characterize a non-positive cardiovascular stimulus by caffeine or CHO use.</p><p>
<table-wrap id="t02" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Cardiovascular responses before and after the respective supplementations before exercise (n= 08)</title></caption><graphic xlink:href="1657-9534-cm-45-02-00072-gt02"/></table-wrap>
</p><p>
<xref ref-type="fig" rid="f01">Figure 1</xref> shows results. Blood glucose was not different at rest before all supplementations. Although, after 30 min of supplementations, before exercise, caffeine-induced BG reductions compared to CHO + Caffeine (87%), CHO alone (83%) or placebo (65%) groups. In addition, BG was different during 40 min of exercise protocol, with caffeine-induced BG reductions compared to CHO + Caffeine (83%) and CHO alone (87%); [F(3,28): 5.3; p &#x0003c;0.001], but there was no significant difference between caffeine alone compared to placebo. Hence, BG was different during 10 min after the exercise protocol, with caffeine-induced BG reductions compared to CHO+Caffeine (85%), CHO alone (84%), or placebo (63%) [F<sub>(3,28)</sub>: 5.3; <italic>p</italic> &#x0003c;0.001].</p><p>
<fig id="f01" fig-type="audiogram" orientation="portrait" position="float"><label>Figure 1.</label><caption><title>Concentration of blood glucose between treatments. Exercise was conducted based on a protocol of 40 min of exercise at 40% of HR reserve. Each data point shows the mean &#x000b1; SEM (n= 8). * Statistical difference is shown between Caffeine group vs. CHO and CHO+Caffeine groups; ** Statistical difference is shown between Caffeine group vs. Placebo, CHO and CHO+Caffeine groups (<italic>p</italic> &#x0003c;0.05, one-way ANOVA with Tukey's post hoc tests).</title></caption><graphic xlink:href="1657-9534-cm-45-02-00072-gf01"/></fig>
</p></sec><sec sec-type="discussion"><title>Discussion</title><p>Past and recent studies with caffeine-induced modifications in glucose homeostasis have been contradictory. However, most studies concerning acute caffeine response to glucose homeostasis revealed increased insulin resistance due to immediate secretion of epinephrine <xref rid="B18" ref-type="bibr">18</xref>. In contrast, most long-term epidemiological studies revealed that long-term caffeine consumption via caffeinated drinks, such as coffee, had a rather beneficial action in glucose homeostasis to reduce the risk of T2DM <xref rid="B19" ref-type="bibr">19</xref>. A recent study showed that in diabetic rats with insulin resistance and secretion deficit, long-term consumption of caffeine improved both sensitivity and glucose-stimulated insulin secretion, regardless of caffeine associated CHO addition; whereas, sucrose itself aggravated insulin resistance. Improved insulin sensitivity resulting from long-term caffeine consumption, in both normal and diabetic rats, was related to reduced body weight and fat <xref rid="B20" ref-type="bibr">20</xref>. </p><p>It has been reported that concentrations of caffeine could directly stimulate the &#x000e2; cell secretion of insulin <xref rid="B20" ref-type="bibr">20</xref>
<sup>,</sup>
<xref rid="B21" ref-type="bibr">21</xref>. Caffeine alter<bold>s</bold> the expression of glucose transporter 2 (GLUT2) and glucokinase in &#x000e2; cells, involved in the phosphorylation of the glucose mechanism and, consequently, with the release of insulin <xref rid="B22" ref-type="bibr">22</xref>. In the muscle, caffeine may improve the expression of GLUT4, by increasing concentrations of Ca<sup>2+</sup> intracellular and also improved expression of AMPK enzyme <xref rid="B22" ref-type="bibr">22</xref>. Caffeine could also be acting on adenosine receptors on the cell membrane of the hepatocyte, which are involved in glycogenolysis and gluconeogenesis <xref rid="B23" ref-type="bibr">23</xref>.</p><p>Although this study was not designed to assess the mechanisms by which caffeine leads to glucose homeostasis, other studies showed increased serum insulin with the ingestion of caffeine <xref rid="B21" ref-type="bibr">21</xref>
<sup>-</sup>
<xref rid="B23" ref-type="bibr">23</xref>. The results obtained by these studies, through measurement of C-peptide concentrations support the hypothesis that caffeine increases insulin concentrations via increased pancreatic secretion of the hormone rather than an alteration in insulin clearance <xref rid="B24" ref-type="bibr">24</xref>
<sup>,</sup>
<xref rid="B25" ref-type="bibr">25</xref>, along with decrease BG concentrations by the association of caffeine with effect of better glucose uptake obtained with exercise <xref rid="B20" ref-type="bibr">20</xref>
<sup>,</sup>
<xref rid="B25" ref-type="bibr">25</xref>.</p><p>Acute supplementation of caffeine and its effects can be seen from two different points: contribution to a suggestive increase of insulin release and BG control. However, it may have an adverse effect, it may have peaks of glucose uptake and cause hypoglycemia <xref rid="B20" ref-type="bibr">20</xref>
<sup>-</sup>
<xref rid="B22" ref-type="bibr">22</xref>
<sup>,</sup>
<xref rid="B24" ref-type="bibr">24</xref>; whereas, the effects of administering caffeine on glucose homeostasis are not clear. In the present study, administering 1.5 mg/kg caffeine during 40 min of exercise contributed to maintenance of BG levels at ~140 mg/dL. It has been proposed that during exercise these diabetic patients need adequate BG maintenance at approximately 100 mg/dL <xref rid="B17" ref-type="bibr">17</xref>
<sup>,</sup>
<xref rid="B26" ref-type="bibr">26</xref>.</p><p>Van Nieuwenhoven <italic>et al</italic>. <xref rid="B27" ref-type="bibr">27</xref>, showed that consumption of 1.4 mg/kg of caffeine and 45 g of glucose administered for 90 min of exercise at 70% of maximal power output (Wmax) resulted in a significant increase of 23% in intestinal absorption of glucose consumption compared with glucose alone. According to the authors, caffeine could influence the activity of glucose transporters in the digestive system increasing BG. In the present study, intake of caffeine associated with CHO bear no difference in BG compared to intake of CHO alone, maybe due to the effect of caffeine on intestinal absorption of glucose, keeping BG to the Caffeine + CHO group the same as supplementation with CHO alone. Yeo <italic>et al</italic>. <xref rid="B28" ref-type="bibr">28</xref>, demonstrated in their study that no difference in BG concentration was noted during exercise with carbohydrate intake associated to caffeine compared to treatment with carbohydrates. </p><p>In relation to chronic use, Conde <italic>et al</italic>. <xref rid="B29" ref-type="bibr">29</xref>, concluded that long-term caffeine intake (1 g/L) prevented development of insulin resistance by elevated blood insulin and lower blood glucose in diabetic rats.</p><p>A study by Noordzij <italic>et al</italic>. <xref rid="B30" ref-type="bibr">30</xref>, revealed that the influence of caffeine on cardiovascular stimulation is directly related to the amount of caffeine consumed. The effect of caffeine on cardiovascular responses is due to the classic effect of caffeine on increased release of catecholamines, which directly influence the sympathetic nervous system and the consequent increase in blood pressure <xref rid="B31" ref-type="bibr">31</xref>. In this study, no significant difference was observed among the groups possibly related to the dosage of 1.4 mg/kg of caffeine.</p><p>Thereby, the results showed in this study pilot, that acute caffeine ingestion in low doses prior to exercise could amplify the peripheral glucose uptake and consumption during aerobic exercise.</p></sec></body><back><ack><title>Acknowledgment </title><p>This work was supported by the Brazilian agencies: CNPq, National Council for Science and Technology and FA, Arauc&#x000e1;ria Foundation from Paran&#x000e1; State. There is no potential conflict of interest.</p></ack><ref-list><title>References 
</title><ref id="B01"><label>1</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><source>Diabetes. Descriptive data 312</source><year>2009</year></element-citation></ref><ref id="B02"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monnier</surname><given-names>L</given-names></name><name><surname>Lapinski</surname><given-names>H</given-names></name><name><surname>Colette</surname><given-names>C</given-names></name></person-group><article-title>Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of patients with T2DM: variations with increasing levels of HbA(1c)</article-title><source>Diabetes Care</source><year>2003</year><volume>3</volume><fpage>881</fpage><lpage>885</lpage><pub-id pub-id-type="pmid">12610053</pub-id></element-citation></ref><ref id="B03"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O'Dea</surname><given-names>K</given-names></name><name><surname>Snow</surname><given-names>P</given-names></name><name><surname>Nestel</surname><given-names>P</given-names></name></person-group><article-title>Rate of starch hydrolysis in vitro as a predictor of metabolic responses to complex carbohydrate in vivo</article-title><source>Am J Clin Nutr</source><year>1981</year><volume>34</volume><fpage>1991</fpage><lpage>1993</lpage><pub-id pub-id-type="pmid">6170218</pub-id></element-citation></ref><ref id="B04"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolever</surname><given-names>TM</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Zeng</surname><given-names>XY</given-names></name><name><surname>Atkinson</surname><given-names>F</given-names></name><name><surname>Brand-Miller</surname><given-names>JC</given-names></name></person-group><article-title>Food glycemic index, as given in glycemic index tables, is a significant determinant of glycemic responses elicited by composite breakfast meals</article-title><source>Am J Clin Nutr</source><year>2006</year><volume>83</volume><fpage>1306</fpage><lpage>1312</lpage><pub-id pub-id-type="pmid">16762941</pub-id></element-citation></ref><ref id="B05"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Voss</surname><given-names>AC</given-names></name><name><surname>Maki</surname><given-names>KC</given-names></name><name><surname>Garvey</surname><given-names>T</given-names></name><name><surname>Hustead</surname><given-names>DS</given-names></name><name><surname>Alish</surname><given-names>C</given-names></name><name><surname>Fix</surname><given-names>B</given-names></name><etal/></person-group><article-title>Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes</article-title><source>Nutrition</source><year>2008</year><volume>24</volume><fpage>990</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">18718737</pub-id></element-citation></ref><ref id="B06"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coggan</surname><given-names>AR</given-names></name><name><surname>Coyle</surname><given-names>EF</given-names></name></person-group><article-title>Reversal of fatigue during prolonged exercise by carbohydrate infusion or ingestion</article-title><source>J Appl Physiol</source><year>1987</year><volume>63</volume><fpage>2388</fpage><lpage>2395</lpage><pub-id pub-id-type="pmid">3325488</pub-id></element-citation></ref><ref id="B07"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyle</surname><given-names>EF</given-names></name><name><surname>Coggan</surname><given-names>AR</given-names></name><name><surname>Hemmert</surname><given-names>MK</given-names></name><name><surname>Ivy</surname><given-names>JL</given-names></name></person-group><article-title>Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate</article-title><source>J Appl Physiol</source><year>1986</year><volume>61</volume><fpage>165</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">3525502</pub-id></element-citation></ref><ref id="B08"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruffo</surname><given-names>AM</given-names></name><name><surname>Osiecki</surname><given-names>R</given-names></name><name><surname>Fernandes</surname><given-names>LC</given-names></name><name><surname>Felipe</surname><given-names>CS</given-names></name><name><surname>Osiecki</surname><given-names>AC</given-names></name><name><surname>Malfatti</surname><given-names>CRM</given-names></name></person-group><article-title>Moderate to high dose of maltodextrin before exercise improves glycogen availability in soleus and liver after prolonged swimming in rats</article-title><source>JEPonline</source><year>2009</year><volume>12</volume><fpage>30</fpage><lpage>38</lpage></element-citation></ref><ref id="B09"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>TE</given-names></name></person-group><article-title>The possible actions of methylxanthines on various tissues</article-title><source>Clin Pharmacol Sport Exerc</source><year>1997</year><fpage>257</fpage><lpage>267</lpage></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paluska</surname><given-names>SA</given-names></name></person-group><article-title>Caffeine and exercise</article-title><source>Curr Sports Med Rep</source><year>2003</year><volume>2</volume><fpage>213</fpage><lpage>219</lpage><pub-id pub-id-type="pmid">12834577</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Diagnosis and classification of diabetes mellitus</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><issue>1</issue><fpage>s62</fpage><lpage>s69</lpage><pub-id pub-id-type="pmid">20042775</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kline</surname><given-names>GM</given-names></name><name><surname>Porcari</surname><given-names>JP</given-names></name><name><surname>Hintermeister</surname><given-names>R</given-names></name></person-group><article-title>Estimation of VO2max from a one-mile track walk, gender, age, and body weight</article-title><source>Med Sci Sports Exerc</source><year>1987</year><volume>19</volume><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type="pmid">3600239</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jackson</surname><given-names>AS</given-names></name><name><surname>Pollock</surname><given-names>ML</given-names></name><name><surname>Graves</surname><given-names>JE</given-names></name><name><surname>Mahar</surname><given-names>MT</given-names></name></person-group><article-title>Reliability and validity of bioelectrical impedance in determining body composition</article-title><source>J Appl Physiol</source><year>1998</year><volume>64</volume><fpage>529</fpage><lpage>534</lpage><pub-id pub-id-type="pmid">3372410</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Siri</surname><given-names>WE</given-names></name></person-group><source>Body composition from fluid spaces and density</source><publisher-loc>Washington DC</publisher-loc><publisher-name>National Academy of Science</publisher-name><year>1961</year></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borg</surname><given-names>G</given-names></name><name><surname>Noble</surname><given-names>BJ</given-names></name></person-group><article-title>Psycophysical bases of perceived exertion</article-title><source>Med Sci Sport Exerc</source><year>1982</year><volume>14</volume><fpage>377</fpage><lpage>381</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huskisson</surname><given-names>EC</given-names></name></person-group><article-title>Measurement of pain</article-title><source>Lancet</source><year>1974</year><volume>2</volume><fpage>1127</fpage><lpage>1131</lpage><pub-id pub-id-type="pmid">4139420</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Diabetes Association</collab></person-group><article-title>Physical Activity/Exercise and Diabetes Mellitus</article-title><source>Diabetes Care</source><year>2006</year><volume>29</volume><fpage>1433</fpage><lpage>1438</lpage><pub-id pub-id-type="pmid">16732040</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keijzers</surname><given-names>GB</given-names></name><name><surname>De Galan</surname><given-names>BE</given-names></name><name><surname>Tack</surname><given-names>CJ</given-names></name><name><surname>Smits</surname><given-names>P</given-names></name></person-group><article-title>Caffeine can decrease insulin sensitivity in humans</article-title><source>Diabetes Care</source><year>2002</year><volume>25</volume><fpage>364</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">11815511</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salazar-Martinez</surname><given-names>E</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Ascherio</surname><given-names>A</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Leitzmann</surname><given-names>MF</given-names></name><name><surname>Stampfer</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Coffee consumption and risk for type 2 diabetes mellitus</article-title><source>Ann Intern Med</source><year>2004</year><volume>140</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14706966</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Jang</surname><given-names>JS</given-names></name><name><surname>Hong</surname><given-names>SM</given-names></name></person-group><article-title>Long-term consumption of caffeine improves glucose homeostasis by enhancing insulinotropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats</article-title><source>Metab Clin Exp</source><year>2007</year><volume>56</volume><fpage>599</fpage><lpage>607</lpage><pub-id pub-id-type="pmid">17445533</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruton</surname><given-names>JD</given-names></name><name><surname>Lemmens</surname><given-names>R</given-names></name><name><surname>Shi</surname><given-names>CL</given-names></name><name><surname>Persson-Sj&#x000f6;gren</surname><given-names>S</given-names></name><name><surname>Westerblad</surname><given-names>H</given-names></name><name><surname>Ahmed</surname><given-names>M</given-names></name></person-group><article-title>Ryanodine receptors of pancreatic beta-cells mediate a distinct context-dependent signal for insulin secretion</article-title><source>FASEB J</source><year>2003</year><volume>17</volume><fpage>301</fpage><lpage>303</lpage><pub-id pub-id-type="pmid">12475892</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>S</given-names></name><name><surname>Scheffler</surname><given-names>TL</given-names></name><name><surname>Gunawan</surname><given-names>AM</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Zeng</surname><given-names>C</given-names></name><name><surname>Hannon</surname><given-names>KM</given-names></name><etal/></person-group><article-title>Chronic elevated calcium blocks AMPK-induced GLUT-4 expression in skeletal muscle</article-title><source>Am J Physiol Cell Physiol</source><year>2009</year><volume>296</volume><issue>1</issue><fpage>c106</fpage><lpage>c115</lpage><pub-id pub-id-type="pmid">18971392</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasuda</surname><given-names>N</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Horizoe</surname><given-names>T</given-names></name><name><surname>Nagata</surname><given-names>K</given-names></name><name><surname>Minami</surname><given-names>H</given-names></name><name><surname>Kawata</surname><given-names>T</given-names></name><etal/></person-group><article-title>Functional characterization of the adenosine receptor contributing to glycogenolysis and gluconeogenesis in rat hepatocytes</article-title><source>Eur J Pharmacol</source><year>2003</year><volume>459</volume><fpage>159</fpage><lpage>166</lpage><pub-id pub-id-type="pmid">12524141</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenberg</surname><given-names>JA</given-names></name><name><surname>Owen</surname><given-names>DR</given-names></name><name><surname>Geliebter</surname><given-names>A</given-names></name></person-group><article-title>Decaffeinated coffee and glucose metabolism in young men</article-title><source>Diabetes Care</source><year>2010</year><volume>33</volume><fpage>278</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">19918017</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu Y-F</surname></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Black</surname><given-names>RM</given-names></name><name><surname>Brown</surname><given-names>PH</given-names></name><name><surname>Lyle</surname><given-names>BJ</given-names></name><name><surname>Liu</surname><given-names>RH</given-names></name><etal/></person-group><article-title>Type 2 diabetes-related bioactivities of coffee: Assessment of antioxidant activity, NF-?B inhibition, and stimulation of glucose uptake</article-title><source>Food Chemistry</source><year>2011</year><volume>124</volume><issue>3</issue><fpage>914</fpage><lpage>920</lpage></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American College of Sports Medicine</collab></person-group><article-title>Exercise and Type 2 diabetes</article-title><source>Med Sci Sport Exerc</source><year>2010</year><volume>42</volume><fpage>2282</fpage><lpage>2303</lpage></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Nieuwenhoven</surname><given-names>MA</given-names></name><name><surname>Brummer</surname><given-names>RM</given-names></name><name><surname>Brouns</surname><given-names>F</given-names></name></person-group><article-title>Gastrointestinal function during exercise: comparison of water, sports drink, and sports drink with caffeine</article-title><source>J Appl Physiol</source><year>2000</year><volume>89</volume><fpage>1079</fpage><lpage>1085</lpage><pub-id pub-id-type="pmid">10956354</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeo</surname><given-names>SE</given-names></name><name><surname>Jentjens</surname><given-names>RLPG</given-names></name><name><surname>Wallis</surname><given-names>GA</given-names></name><name><surname>Jeukendrup</surname><given-names>AE</given-names></name></person-group><article-title>Caffeine increases exogenous carbohydrate oxidation during exercise</article-title><source>J Appl Physiol</source><year>2005</year><volume>99</volume><fpage>844</fpage><lpage>850</lpage><pub-id pub-id-type="pmid">15831802</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conde</surname><given-names>SV</given-names></name><name><surname>Nunes da Silva</surname><given-names>T</given-names></name><name><surname>Gonzalez</surname><given-names>C</given-names></name><name><surname>Mota Carmo</surname><given-names>M</given-names></name><name><surname>Monteiro</surname><given-names>EC</given-names></name><name><surname>Guarino</surname><given-names>MP</given-names></name></person-group><article-title>Chronic caffeine intake decreases circulating catecholamines and prevents diet-induced insulin resistance and hypertension in rats</article-title><source>Br J Nut</source><year>2012</year><volume>107</volume><issue>1</issue><fpage>86</fpage><lpage>95</lpage></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noordzij</surname><given-names>M</given-names></name><name><surname>Uiterwaal</surname><given-names>CS</given-names></name><name><surname>Arends</surname><given-names>LR</given-names></name><name><surname>Kok</surname><given-names>FJ</given-names></name><name><surname>Grobbee</surname><given-names>DE</given-names></name><name><surname>Geleijns</surname><given-names>JM</given-names></name></person-group><article-title>Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials</article-title><source>J Hypertens</source><year>2005</year><volume>23</volume><issue>5</issue><fpage>921</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">15834273</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nurminen</surname><given-names>ML</given-names></name><name><surname>Niittynen</surname><given-names>L</given-names></name><name><surname>Korpela</surname><given-names>R</given-names></name><name><surname>Vapaatalo</surname><given-names>H</given-names></name></person-group><article-title>Coffee, caffeine and blood pressure: a critical review</article-title><source>Eur J Clin Nutr</source><year>1999</year><volume>53</volume><issue>11</issue><fpage>831</fpage><lpage>839</lpage><pub-id pub-id-type="pmid">10556993</pub-id></element-citation></ref></ref-list></back></article>